Claude Cowork 2.0 introduces direct computer control, a feature that allows users to assign tasks like managing files, navigating applications and drafting documents directly to the AI. According to ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

New Delhi: The government has proposed greater control over foreign-funded assets if organizations that receive funds from overseas sources lose their registration. The Foreign Contribution ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

Did our AI summary help? The burden of digital eye strain is increasing more than ever. Hours spent in front of screens along with few other aspects leads to dryness, headaches and inconsistent ...

Call your agents. Or better yet, code them—using sentences as dead-simple as this one. AI assistants that can handle work and everyday personal tasks, all powered by brisk English-language commands ...

It's a message so clear that anyone with fancy working eyeballs should be able to get it. I'm blind…yes really. We used the new caution tape theme that's on my suit and extended it to the board with a ...

Many people believe closing their eyes sharpens hearing, but that is not always true. In noisy settings, participants struggled more to hear faint sounds with their eyes closed, while matching visuals ...

Mouse numbers in Western Australia are already at plague proportions, and a researcher says immediate action is needed to stop them from getting completely out of control. A regionally based pest ...

Did our AI summary help? The government's move to potentially expand the use of Section 69A of the Information Technology Act beyond the Ministry of Electronics and IT (MeitY) comes at a time when the ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...